Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
33 employees
Cellanome, a synthetic biology firm, leverages a multi-omics platform for innovative molecular solutions.
HQ
Founded
2020
Cellanome is a synthetic biology company focused on developing an automated multi-omics platform to enhance the understanding of individual cell behaviors, interactions, and functions. The platform integrates molecular biology, biochemistry, microfluidics, integrated sensors, and genome sequencing to enable researchers to conduct iterative live cell phenotypic and functional assays at scale. This technology broadens the range of cell types and functions accessible to scientists, facilitating novel solutions to complex biological challenges.
Cellanome has made significant strides in the field of synthetic biology by providing tools that allow for massively parallel analysis of cellular responses. This innovation has empowered researchers to explore new questions and gain deeper insights into cellular mechanisms. The company's impact is evident in its ability to link specific cellular responses to various stimuli, advancing the capabilities of biological research and development.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Synthetic Biology
Technology
Analytics, AI, Machine Learning
Tags
Biotech, Platform
Model Types
SaaS
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Research
Geographic Exposure
Global
When was Cellanome founded?
Cellanome was founded in 2020.
Where is Cellanome's headquarters located?
Cellanome's headquarters is located in Palo Alto, CA, US.
When was Cellanome's last funding round?
Cellanome's most recent funding round was for $40.7M (USD) in August 2022.
How many employees does Cellanome have?
Cellanome has 33 employees as of Feb 5, 2024.
How much has Cellanome raised to-date?
As of July 05, 2023, Cellanome has raised a total of $63.7M (USD) since Aug 5, 2022.
Add Comparison
Total Raised to Date
$63.7M
USD
Last Update Aug 5, 2022
Last Deal Details
$40.7M
USD
Aug 5, 2022
Series A
Current Employees
33
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts